Genie L. Bailey
Brown University(US)Stanley Street Treatment and Resources(US)
Publications by Year
Research Areas
Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes, HIV, Drug Use, Sexual Risk, Prenatal Substance Exposure Effects, Pain Management and Opioid Use
Most-Cited Works
- → Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial(2017)683 cited
- → Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial(2019)270 cited
- → Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder(2018)238 cited
- → Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder(2017)208 cited
- → Buprenorphine Implants for Treatment of Opioid Dependence(2010)171 cited
- → Randomized Controlled Trial of Osmotic-Release Methylphenidate With Cognitive-Behavioral Therapy in Adolescents With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders(2011)125 cited
- → Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment(2015)116 cited
- → Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification(2016)107 cited
- → Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder(2019)106 cited
- → Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone(2013)96 cited